Asvagj Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 50.00 K
as on 10-12-2024
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
About Asvagj Pharmaceuticals
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Vivek Shrivastav, Abhishek Shrivastava, and Siddhita Srivastava serve as directors at the Company.
- CIN/LLPIN
U74999UR2022PTC013631
- Company No.
013631
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Asvagj Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Shrivastav  | Director | 23-Feb-2022 | Current |
| Abhishek Shrivastava | Director | 23-Feb-2022 | Current |
| Siddhita Srivastava | Director | 05-Jul-2024 | Current |
Financial Performance of Asvagj Pharmaceuticals.
Enhance accessibility to Asvagj Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Asvagj Pharmaceuticals?
Unlock access to Asvagj Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Anfira Nutraceuticals Private LimitedActive 2 years 10 monthsVivek Shrivastav, Abhishek Shrivastava and 1 more are mutual person
- Asvagj Infracon Private LimitedActive 7 years 1 month
Vivek Shrivastav, Abhishek Shrivastava and 1 more are mutual person
- Airavat Tradecom Private LimitedActive 10 years 2 months
Vivek Shrivastav and Abhishek Shrivastava are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Asvagj Pharmaceuticals?
Asvagj Pharmaceuticals has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Asvagj Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Asvagj Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
